US Oncology Network names chief surgical officer

July 15, 2018
The US Oncology Network appointed breast surgeon Loren Rourke, MD, MHCM, as its chief surgical officer.

Leukemia & Lymphoma Society appoints board members, names chief operating officer

July 14, 2018
The Leukemia & Lymphoma Society appointed five new members to its board of directors and also named its new chief operating officer.
Meeting News

Nivolumab prior to surgery appears safe, effective in metastatic renal cell carcinoma

July 13, 2018
CHICAGO — Nivolumab plus or minus bevacizumab or ipilimumab prior to surgery appeared safe and demonstrated promising clinical activities in…
In the Journals Plus

MGMT promoter methylation prognostic biomarker for low-grade glioma

July 13, 2018
O6-methylgaunine-DNA-methyltransferase, or MGMT, promoter methylation appeared to be significantly associated with PFS and OS among patients with…
In the Journals Plus

Emergency colon cancer surgery conducted over weekend has poorer outcomes

July 13, 2018
Patients who underwent weekend emergency surgery for colon cancer appeared to have greater mortality and more severe complication rates than patients…
In the Journals

IVC filter increases 30-day mortality in VTE with contraindication to anticoagulation

July 13, 2018
Patients with venous thromboembolism and a contraindication to anticoagulation who received an inferior vena cava filter had a significantly…
In the Journals Plus

Population-level decreases in alcohol, tobacco use could reduce cancer mortality

July 13, 2018
Population-level reductions in tobacco and alcohol consumption could lower cancer mortality, according to findings from a population-based cohort

Integrating yoga into health care benefits numerous patients

July 13, 2018
As the body of research validating the health benefits of yoga continues to grow, the ancient practice is becoming increasingly popular as a method…
Feature

CAR T-cell therapy may be effective for colorectal cancer

July 13, 2018
Chimeric antigen receptor T-cell therapy may be an effective treatment strategy for colorectal cancer, according to study results. Adam
Meeting News

Alternative chemotherapy dosing schedule appears safe in patients with bladder cancer

July 12, 2018
CHICAGO — A “split” schedule of cisplatin-based chemotherapy conferred lower pathologic response rates compared with a convention…

Analysis: CMS stopping risk adjustment payments leaves insurance premiums in limbo, jeopardizes Affordable Care Act

July 12, 2018
The CMS decision to stop further collections or payments under the risk adjustment program leaves many questions about future health coverage and…
In the Journals

Gastric cancer screening cost-effective in some U.S. populations

July 12, 2018
Endoscopic noncardia gastric cancer screening might be cost effective among high-risk ethnicities in the United States, such as Hispanics, blacks and…
In the Journals Plus

Substantial variation exists in surgeon acceptance of more limited breast cancer surgery

July 12, 2018
Surgeon acceptance of findings recommending against axillary lymph node dissection for breast cancer varied widely and appeared more common among…
In the Journals Plus

Pancreatic adenocarcinoma mortality risk outweighed by other causes after 9 years

July 12, 2018
Patients who survived 8.75 years after being diagnosed with pancreatic adenocarcinoma were more likely to die of other causes than of their cancer…
In the Journals Plus

Checkpoint inhibitors improve survival for metastatic melanoma with brain metastases

July 12, 2018
Treatment with checkpoint blockade immunotherapy more than doubled the rate of 4-year OS among patients with melanoma and metastatic brain…
Feature

Androgen deprivation therapy increases risk for rheumatoid arthritis

July 12, 2018
Treatment with androgen deprivation therapy appeared to increase risk for rheumatoid arthritis among older men with localized prostate cancer…

FDA warns against using sterile drugs from Ranier’s Compounding Laboratory

July 11, 2018
The FDA is warning health care professionals not to use sterile drug products from Ranier’s Compounding Laboratory due to lack of sterility…

Ninlaro maintenance therapy extends PFS in posttransplant myeloma

July 11, 2018
Maintenance therapy with ixazomib significantly extended PFS compared with placebo for certain patients with myeloma, according to the agent’s…

Phase 3 trial of ibrutinib plus R-CHOP for aggressive lymphoma subtype fails to meet primary endpoint

July 11, 2018
A phase 3 trial designed to evaluate the addition of ibrutinib to standard chemotherapy for treatment of newly diagnosed nongerminal center B-cell…
FDA News

FDA grants priority review to Keytruda for advanced liver cancer

July 11, 2018
The FDA granted priority review to pembrolizumab for previously treated patients with advanced hepatocellular carcinoma, the agent’s…